Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine as adjunctive sedation for brachial plexus block in upper limb surgery
ChiCTR2200065489Phase 4Recruiting
- Sponsor
- Quanzhou First Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Quanzhou First Hospital. Primary endpoints: Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scale and Bispectral index (BIS). Started Nov 2022; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200065489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065489.